首页> 外文期刊>Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists >Complementary Role of Fenestrated/Branched Endografting and the Chimney Technique in the Treatment of Pararenal Aneurysms After Open Abdominal Aortic Repair
【24h】

Complementary Role of Fenestrated/Branched Endografting and the Chimney Technique in the Treatment of Pararenal Aneurysms After Open Abdominal Aortic Repair

机译:有孔/分支内移植和烟囱技术在腹主动脉开放性修复后肾旁动脉瘤中的辅助作用

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To evaluate the totally endovascular techniques for treating complex pararenal aortic aneurysms after open repair of abdominal aortic aneurysm. Methods: This retrospective study involved 34 men (mean age 74 years) with pararenal aortic aneurysms (22 pseudoaneurysms and 12 para-anastomotic aneurysms) that developed a median 11 years (range 4-22) after the primary surgical reconstruction. The median infrarenal neck length was 2 mm (range 0-9). Total endovascular aneurysm repair (EVAR) included the use of fenestrated (f-EVAR; n=17), branched (b-EVAR; n=11), combined f-EVAR/b-EVAR (n=1), and chimney (ch-EVAR; n=4) grafts and the sandwich technique (n=1). The primary outcome was aneurysm shrinkage >5 mm at latest follow-up. Secondary outcomes were target vessel patency, 30-day mortality, late survival, absence of type I and III endoleak, clinical success, and reintervention rate. Results: Technical success was 97% (n=33/34), while clinical success was achieved in 32 (94%) patients. The 30-day mortality was 3% (n=1/34). Mean follow-up was 23.2 +/- 16.6 months. One patient was lost to follow-up, and 1 patient underwent late open conversion for endograft infection. Six (18%) of the 33 surviving patients required a reintervention. Primary patency of the target aortic branches was 98% (109/111). Mean aneurysm diameter decreased from 64.1 +/- 10.2 to 56.7 +/- 16.9 mm (p<0.001) at latest follow-up. Midterm mortality was 12.1% (4/33). Estimated survival rates at 1 and 2 years were 93.9% and 90.9, respectively. Conclusion: Use of f-EVAR, b-EVAR, and ch-EVAR allows effective treatment of postsurgical pararenal aneurysms based on a clear algorithm and patient selection, highlighting the complementary character of these less invasive approaches.
机译:目的:评价开放式修复腹主动脉瘤后复杂的肾上主动脉瘤的全腔内治疗技术。方法:这项回顾性研究涉及34名男性(平均年龄74岁)患有肾上主动脉瘤(22个假性动脉瘤和12个副吻合动脉瘤),这些患者在一次外科手术重建后平均发展了11年(4-22岁)。中肾下颈部长度为2毫米(范围为0-9)。总血管内动脉瘤修复(EVAR)包括开窗(f-EVAR; n = 17),分支(b-EVAR; n = 11),f-EVAR / b-EVAR(n = 1)和烟囱( ch-EVAR; n = 4)移植和三明治技术(n = 1)。最主要的结果是在最近的随访中动脉瘤缩小> 5 mm。次要结果为目标血管通畅性,30天死亡率,晚期生存,不存在I型和III型内漏,临床成功率和再干预率。结果:技术成功率为97%(n = 33/34),而临床成功率为32(94%)患者。 30天死亡率为3%(n = 1/34)。平均随访时间为23.2 +/- 16.6个月。 1例患者失去随访,1例患者因内移植物感染接受了晚期开放性转换。 33名幸存患者中有6名(18%)需要再次干预。目标主动脉分支的主要通畅率为98%(109/111)。在最近的随访中,平均动脉瘤直径从64.1 +/- 10.2毫米降低到56.7 +/- 16.9毫米(p <0.001)。中期死亡率为12.1%(4/33)。 1年和2年的估计生存率分别为93.9%和90.9。结论:f-EVAR,b-EVAR和ch-EVAR的使用可基于明确的算法和患者选择来有效治疗术后肾旁动脉瘤,突出了这些微创方法的互补性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号